|
|
||||||||


*
Institut National de la Santé et de la Recherche Médicale Unité 463, Nantes, France; and
Institut National de la Santé et de la Recherche Médicale Unité 395, Toulouse, France
The two main constraints that currently limit a broader usage of T
cell therapy against viruses are the delay required to obtain specific
T cells and the safety of the selection procedure. In the present work
we developed a generally applicable strategy that eliminates the need
for APC for timing reasons, and the need for infectious viral strains
for safety concerns. As a model, we used the selection of T lymphocytes
specific for the immunodominant CMV phosphoprotein pp65. PBMC from
healthy seropositive donors were first depleted of IL-2R
-chain
CD25+ cells and were then stimulated for 2496 h with
previously defined peptide Ags or with autologous PBMC infected with a
canarypox viral vector encoding the total pp65 protein (ALVAC-pp65).
Subsequent immunomagnetic purification of newly CD25-expressing cells
allowed efficient recovery of T lymphocytes specific for the initial
stimuli, i.e., for the already known immunodominant epitope
corresponding to the peptides used as a model or for newly defined
epitopes corresponding to peptides encoded by the transfected pp65
protein. Importantly, we demonstrated that direct PBMC stimulation
allowed recovery not only of CD8+ memory T lymphocytes, but
also of the CD4+ memory T cells, which are known to be
crucial to ensure persistence of adoptively transferred immune memory.
Finally, our analysis of pp65-specific T cells led to the
identification of several new helper and cytotoxic epitopes. This work
thus demonstrates the feasibility of isolating memory T lymphocytes
specific for a clinically relevant protein without the need to prepare
APC, to use infectious viral strains, or to identify immunodominant
epitopes.
This article has been cited by other articles:
![]() |
G. Li Pira, L. Bottone, F. Ivaldi, R. Pelizzoli, F. Del Galdo, L. Lozzi, L. Bracci, A. Loregian, G. Palu, R. De Palma, et al. Identification of new Th peptides from the cytomegalovirus protein pp65 to design a peptide library for generation of CD4 T cell lines for cellular immunoreconstitution Int. Immunol., May 1, 2004; 16(5): 635 - 642. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Papanicolaou, J.-B. Latouche, C. Tan, J. Dupont, J. Stiles, E. G. Pamer, and M. Sadelain Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele Blood, October 1, 2003; 102(7): 2498 - 2505. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Allart, J. Lule, B. Serres, T. Jones, J.-L. Davignon, F. Malecaze, and C. Davrinche Impaired Killing of HCMV-Infected Retinal Pigment Epithelial Cells by Anti-pp65 CD8+ Cytotoxic T Cells Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 665 - 671. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |